We show a SIRT3-Akt-c-Myc signaling axis that underlies the progression of prostate cancer (Figure 7), and suggest that the molecular and pathological determination of SIRT3 may be used in prostate cancer diagnosis/prognosis. This evidence concerns the gene MYC and prostate cancer.